Close Menu

Life After Genentech

David Ebersman, who was the chief financial officer at Genentech until it was acquired by Roche, has a new gig. According to TechCrunch, he is the new CFO of Facebook, replacing Gideon Yu. Ebersman had been at Genentech for 15 years. He will formally start at Facebook in September. Do we see a social networking angle for pharmaceutical development in our future?

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

President Donald Trump might not approve the stricter standards the US Food and Drug Administration is developing for authorizing a SARS-CoV-2 vaccine, according to Politico.

Wired reports that Oxitec has now developed a genetically modified fall armyworm.

A large genetic study finds SARS-CoV-2 viruses with a certain variant are spreading more than others, according to the Washington Post.

In Nature this week: sister-chromatid-sensitive chromosome conformation capture approach, and more.